NCT05746559 · Interventional trial
ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE
Overall registry status Terminated
Phase 3
Conditions CKD, Cardiac Disease, Cardiopulmonary Bypass, Chronic Kidney Disease
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory